Ternary Alloy Cu–Ru–Ir Nanocages for Acidic Oxygen Evolution Reaction
Source abstract
Abstract
The oxygen evolution reaction (OER) is a key process for renewable energy technologies, but the design of economical electrocatalysts that are robust in acidic media over long lifecycles is an unsolved issue. Here, we report an example of trimetallic (i.e., ternary) Cu x Ru y Ir z alloys with tunable compositions, prepared as nanocages (NCs) with 10–11.5 nm diameters. The Cu x Ru y Ir z NCs were prepared using 10.3 ± 1.5 nm Cu cuboctahedral nanoparticles (NPs) as sacrificial cores for the subsequent overgrowth of Ru–Ir alloy shells, with average thicknesses of 4–5 atomic overlayers. Cu@Ru y Ir z core–shell NPs were then subjected to chemical etching in 3.0 M HCl at 60 °C, which completely removed the Cu cores, leaving behind hollow NC structures with high surface area-to-volume ratios. Importantly, the Cu etching process resulted in the inclusion of Cu atoms into the Ru–Ir shells, directly forming ternary Cu–Ru–Ir alloys in which the Cu:Ru/Ir ratio was controllable by etching time. Composition tunability was explored across a wide range of Cu, Ru, and Ir ratios. Electrochemical measurements of various Cu x Ru y Ir z NCs in 0.1 M HClO 4 revealed that the OER activity is highly sensitive to the amount of Cu in the ternary alloys. Cu 10 Ru 19 Ir 71 NCs were the most active OER catalysts, requiring a low overpotential of 255 mV to achieve a current density of 10 mA cm –2 . The NC structures were unchanged postcatalysis. Compared to that of conventional Ru–Ir binary alloys, the enhancement of the OER activity in Cu x Ru y Ir z NCs underlines the important role played by Cu in modifying the electronic properties of the ternary alloy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrocatalysts for Energy Conversion · Fuel Cells and Related Materials · Advanced battery technologies research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, University of Texas at Austin, Welch Hall 4.428, 105 E. 24th St. Stop A5300, Austin, Texas 78712-0165, United States
Funding
Division of Chemistry · Welch Foundation
References (48)
Show source-provided references
1. 10.1021/acscatal.8b0271210.1021/acscatal.8b02712 ↗
2. 10.1039/C4CY00669K10.1039/C4CY00669K ↗
3. 10.1039/C4CS00470A10.1039/C4CS00470A ↗
4. 10.1002/adfm.20240076710.1002/adfm.202400767 ↗
5. 10.1016/j.apsadv.2021.10018410.1016/j.apsadv.2021.100184 ↗
6. 10.1002/chem.20230020510.1002/chem.202300205 ↗
7. 10.1021/jacs.1c1096310.1021/jacs.1c10963 ↗
8. 10.1021/jacs.4c1178810.1021/jacs.4c11788 ↗
9. 10.1016/j.cej.2022.13569910.1016/j.cej.2022.135699 ↗
10. 10.1016/S1872-2067(23)64554-110.1016/S1872-2067(23)64554-1 ↗
11. 10.1002/adma.20221056510.1002/adma.202210565 ↗
12. 10.1002/idm2.1205910.1002/idm2.12059 ↗
13. 10.1002/aenm.20190411410.1002/aenm.201904114 ↗
14. 10.1002/adfm.20160468810.1002/adfm.201604688 ↗
15. 10.26599/NRE.2023.912005610.26599/NRE.2023.9120056 ↗
16. 10.1039/D3NH00156C10.1039/D3NH00156C ↗
17. 10.1039/C9CS00607A10.1039/C9CS00607A ↗
18. 10.1016/j.nanoen.2020.10527010.1016/j.nanoen.2020.105270 ↗
19. 10.1021/acs.accounts.6b0046910.1021/acs.accounts.6b00469 ↗
20. 10.1002/anie.20210227510.1002/anie.202102275 ↗
21. 10.1039/D2TA08066D10.1039/D2TA08066D ↗
22. 10.1039/D3TA01280H10.1039/D3TA01280H ↗
23. 10.1016/j.matt.2025.10209110.1016/j.matt.2025.102091 ↗
24. 10.1021/acs.jpca.0c0299110.1021/acs.jpca.0c02991 ↗
25. 10.1016/j.matt.2020.07.02710.1016/j.matt.2020.07.027 ↗
26. 10.1002/ange.20190173210.1002/ange.201901732 ↗
27. 10.1021/acs.jpcc.7b1097410.1021/acs.jpcc.7b10974 ↗
28. 10.1021/acs.chemmater.9b0413810.1021/acs.chemmater.9b04138 ↗
29. 10.1021/acscatal.3c0167610.1021/acscatal.3c01676 ↗
30. Yan, G.; Liu, W.; Pu, S.; Gao, W.; Liang, G. Method for Synthesizing Iridium (III) Triacetylacetonate. CN1269827C, August 16, 2006. https://patents.google.com/patent/CN1269827C/en (accessed 2025–06–07).
31. Ferreira, T.; Rasband, W. ImageJ User Guide; U. S. National Institutes of Health: Bethesda, Maryland, USA, 2012, 1997–2018. https://imagej.net/ij/.
32. Smith T. J. · 2007 · 7310.1016/B978-044451958-0.50005-7 ↗
33. 10.1021/acscatal.0c0204610.1021/acscatal.0c02046 ↗
34. 10.1039/D1CY00639H10.1039/D1CY00639H ↗
35. 10.1021/jacs.2c0253810.1021/jacs.2c02538 ↗
36. 10.1039/D0NA00061B10.1039/D0NA00061B ↗
37. 10.1038/s41467-022-33236-610.1038/s41467-022-33236-6 ↗
38. 10.1021/jp501418710.1021/jp5014187 ↗
39. 10.1103/PhysRevB.48.1168510.1103/PhysRevB.48.11685 ↗
40. 10.1038/s41598-019-45401-x10.1038/s41598-019-45401-x ↗
41. Simon N. J. · 1992
42. 10.1021/acsomega.9b0375710.1021/acsomega.9b03757 ↗
43. 10.3390/pr1005100810.3390/pr10051008 ↗
44. 10.1002/advs.20150025210.1002/advs.201500252 ↗
45. 10.1093/nsr/nww06210.1093/nsr/nww062 ↗
46. Okamoto H. · 201610.31399/asm.hb.v03.9781627081634 ↗
47. 10.1038/s41467-022-30379-410.1038/s41467-022-30379-4 ↗
48. 10.3390/catal1310134610.3390/catal13101346 ↗